Lower FASN protein levels, a central lipogenesis enzyme that catalyses de novo saturated FA biosynthesis, has been associated with hyperglycaemia, insulin resistance and obesity (Mayas et al., 2010). This evidence concerns the gene FASN and Insulin resistance.